Jyoti Mayadev

University of California, Davis

Papers

1

Total Citations

459

H-Index

1

About

Dr. Jyoti Mayadev is a leading radiation oncologist whose research focuses on improving treatment outcomes for prostate and gynecologic cancers, with a particular emphasis on precision radiotherapy and comparative effectiveness. Her seminal work includes a landmark 2012 study that systematically compared prostate-specific antigen (PSA) free survival outcomes across low, intermediate, and high-risk prostate cancer patients treated with various radical therapies. This highly cited paper (459 citations) provided critical insights into the sensitivity of PSA as a measurement tool for treatment effectiveness, helping to establish benchmarks for evaluating therapeutic options. Dr. Mayadev's contributions have significantly advanced the understanding of risk-adapted treatment strategies, enabling more personalized care for patients. Her research has been instrumental in shaping clinical guidelines and improving survival outcomes, particularly through the integration of advanced imaging and targeted radiation techniques. Recognized for her dedication to evidence-based oncology, Dr. Mayadev continues to influence the field through her rigorous comparative studies and commitment to translating research into tangible patient benefits.

Research Focus

Key Achievements

1
H-Index
1
Papers
459
Total Citations
459
Avg Citations/Paper
🏆 Most Cited Paper
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
459 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: University of California, Davis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago